4//SEC Filing
Collins Helen Louise 4
Accession 0001415889-24-004012
CIK 0001672619other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:46 PM ET
Size
5.5 KB
Accession
0001415889-24-004012
Insider Transaction Report
Form 4
Collins Helen Louise
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2024-02-13+185,000→ 185,000 totalExercise: $14.85Exp: 2034-02-12→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001701247
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 8:46 PM ET
- Size
- 5.5 KB